01:50 PM EDT, 09/16/2025 (MT Newswires) -- Health care stocks advanced Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.

The iShares Biotechnology ETF (IBB) increased 0.2%.

In corporate news, Eli Lilly ( LLY ) shares rose 2.7% after the company said Tuesday it plans to build a $5 billion plant in Goochland County, Virginia, to make active pharmaceutical ingredients and drug products. Separately, Eli Lilly's ( LLY ) investigational oral weight-loss drug orforglipron could be approved by the US Food and Drug Administration before the end of the year under a new one-to-two-month priority review process, Reuters reported.

A New York state judge on Tuesday dismissed two terrorism-related counts against Luigi Mangione over the December 2024 killing of Brian Thompson, a UnitedHealth ( UNH ) executive, according to media reports. Mangione remains charged with second-degree murder, according to the reports. UnitedHealth ( UNH ) shares were down 1.7%.

The US Food and Drug Administration issued a warning letter to Hims & Hers Health ( HIMS ) on Sept. 9, stating that claims on its website about its compounded semaglutide product are false or misleading. The letter was made available to the public on Tuesday. Hims shares fell 5.8% recently.